These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9192370)

  • 1. A field trial of oil adjuvanten trivalent Actinobacillus pleuropneumoniae vaccine.
    Oishi E; Kitajima T; Nakamura H; Matsuda C; Amimoto K; Yasuhara H
    J Vet Med Sci; 1997 May; 59(5):421-3. PubMed ID: 9192370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae.
    Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S
    Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of the combined vaccine prepared from cell-free-antigen of Actinobacillus pleuropneumoniae serotypes 1, 2 and 5 in pigs.
    Oishi E; Kitajima T; Koyama Y; Ohgitani T; Katayama S; Okabe T
    J Vet Med Sci; 1995 Dec; 57(6):1125-8. PubMed ID: 8720063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue reaction and immunity in swine immunized with Actinobacillus pleuropneumoniae vaccines.
    Willson PJ; Rossi-Campos A; Potter AA
    Can J Vet Res; 1995 Oct; 59(4):299-305. PubMed ID: 8548692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia.
    Haga Y; Ogino S; Ohashi S; Ajito T; Hashimoto K; Sawada T
    J Vet Med Sci; 1997 Feb; 59(2):115-20. PubMed ID: 9070983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of protective immunity and inflammatory responses of pigs following immunization with different Actinobacillus pleuropneumoniae preparations with and without adjuvants.
    Hall W; Molitor TW; Joo HS; Pijoan C
    Vet Immunol Immunopathol; 1989 Sep; 22(2):175-86. PubMed ID: 2815578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with inactivated vaccines containing the Apx toxins.
    Chiers K; van Overbeke I; De Laender P; Ducatelle R; Carel S; Haesebrouck F
    Vet Q; 1998 Apr; 20(2):65-9. PubMed ID: 9563163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
    van den Bosch H; Frey J
    Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of secreted virulence factors in Actinobacillus pleuropneumoniae bacterin preparation: a comparison.
    Fedorka-Cray PJ; Stine DL; Greenwald JM; Gray JT; Huether MJ; Anderson GA
    Vet Microbiol; 1993 Oct; 37(1-2):85-100. PubMed ID: 8296454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 10 of pigs vaccinated with bacterins consisting of A. pleuropneumoniae serotype 10 grown under NAD-rich and NAD-restricted conditions.
    van Overbeke I; Chiers K; Donne E; Ducatelle R; Haesebrouck F
    J Vet Med B Infect Dis Vet Public Health; 2003 Aug; 50(6):289-93. PubMed ID: 14629000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with a vaccine containing Apx toxins and transferrin-binding proteins.
    Van Overbeke I; Chiers K; Ducatelle R; Haesebrouck F
    J Vet Med B Infect Dis Vet Public Health; 2001 Feb; 48(1):15-20. PubMed ID: 11254095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of serotype-specific vaccine candidate genes in Actinobacillus pleuropneumoniae and heterologous immunization with Propionibacterium acnes.
    Lei L; Sun C; Lu S; Feng X; Wang J; Han W
    Vaccine; 2008 Nov; 26(49):6274-80. PubMed ID: 18835316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of different doses of antigen for intradermal administration in pigs: the Actinobacillus pleuropneumoniae model.
    Bernardy J; Nechvatalova K; Krejci J; Kudlacková H; Brazdova I; Kucerova Z; Faldyna M
    Vaccine; 2008 Nov; 26(50):6368-72. PubMed ID: 18824203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.
    Shin MK; Kang ML; Jung MH; Cha SB; Lee WJ; Kim JM; Kim DH; Yoo HS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):132-9. PubMed ID: 23206402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-protection experiments in pigs vaccinated with Actinobacillus pleuropneumoniae subtypes 1A and 1B.
    Jolie RA; Mulks MH; Thacker BJ
    Vet Microbiol; 1995 Aug; 45(4):383-91. PubMed ID: 7483251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field experience with two different vaccination strategies aiming to control infections with Actinobacillus pleuropneumoniae in a fattening pig herd.
    Sjölund M; Wallgren P
    Acta Vet Scand; 2010 Mar; 52(1):23. PubMed ID: 20334700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of pig lungs following an experimental challenge with Actinobacillus pleuropneumoniae serotype 1 and 5 in pigs inoculated with either hemolysin protein and/or outer membrane proteins.
    Madsen ME; Carnahan KG; Thwaits RN
    FEMS Microbiol Lett; 1995 Sep; 131(3):329-35. PubMed ID: 7557344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
    Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
    Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological cross-reactivity between a porcine Actinobacillus strain and Haemophilus pleuropneumoniae.
    Rosendal S; Mittal KR
    Can J Comp Med; 1985 Apr; 49(2):164-70. PubMed ID: 3926287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunization of pigs with viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces pulmonary and systemic antibodies and protects against homologous aerosol challenge.
    Hensel A; Stockhofe-Zurwieden N; Petzoldt K; Lubitz W
    Infect Immun; 1995 Aug; 63(8):3048-53. PubMed ID: 7622229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.